GO
Loading...

Bristol-Myers Squibb Co

More

  • Midday Glance: Pharmaceuticals companies Friday, 26 Dec 2014 | 1:20 PM ET

    Baxter International Inc. rose$. 12 or. 2 percent, to $74.57. Bristol-Myers Squibb Co. rose$. 43 or. 7 percent, to $59.58. Hospira fell$. 09 or. 1 percent, to $62.51.

  • Early Glance: Pharmaceuticals companies Friday, 26 Dec 2014 | 10:23 AM ET

    Baxter International Inc. rose$. 10 or. 1 percent, to $74.55. Bristol-Myers Squibb Co. rose$. 72 or 1.2 percent, to $59.87. Hospira rose$. 32 or. 5 percent, to $62.92.

  • Early Glance: Pharmaceuticals companies Wednesday, 24 Dec 2014 | 10:23 AM ET

    Baxter International Inc. rose$. 11 or. 1 percent, to $74.60. Bristol-Myers Squibb Co. rose$. 21 or. 4 percent, to $59.37. Hospira rose$. 12 or. 2 percent, to $62.79.

  • Final Glance: Pharmaceuticals companies Tuesday, 23 Dec 2014 | 6:07 PM ET

    Baxter International Inc. fell$. 21 or. 3 percent, to $74.49. Bristol-Myers Squibb Co. fell $1.90 or 3.1 percent, to $59.16. Hospira fell$. 17 or. 3 percent, to $62.67.

  • Midday Glance: Pharmaceuticals companies Tuesday, 23 Dec 2014 | 1:22 PM ET

    Baxter International Inc. rose$. 12 or. 2 percent, to $74.82. Bristol-Myers Squibb Co. fell $2.15 or 3.5 percent, to $58.92. Hospira fell$. 45 or. 7 percent, to $62.40.

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • Final Glance: Pharmaceuticals companies Monday, 22 Dec 2014 | 7:19 PM ET

    Baxter International Inc. rose$. 22 or. 3 percent, to $74.70. Bristol-Myers Squibb Co. fell$. 24 or. 4 percent, to $61.06. Hospira rose$. 18 or. 3 percent, to $62.84.

  • FDA approves new melanoma drug from Bristol-Myers Monday, 22 Dec 2014 | 4:23 PM ET

    WASHINGTON— The Food and Drug Administration granted accelerated approval Monday to a new drug from Bristol-Myers Squibb to treat the deadliest form of skin cancer. Since 2011, the FDA has approved seven new drugs for the form of skin cancer, including Opdivo. FDA regulators cleared the drug for patients who have previously been treated with an older...

  • Dec 22- The U.S. Food and Drug Administration approved Bristol-Myers Squibb Co's skin cancer drug, more than three months before the scheduled review date. The drug is the second PD-1 inhibitor to be approved by the FDA, the first being Merck& Co Inc's Keytruda in September. The FDA was scheduled to review the drug on March 30.

  • FDA approves Bristol-Myer's skin cancer drug Monday, 22 Dec 2014 | 2:32 PM ET

    Dec 22- The U.S. Food and Drug Administration granted an accelerated approval to Bristol-Myers Squibb Co's drug for an advanced form of skin cancer. The drug, Opdivo, inhibits the action of the protein PD-1, which prevents the body's immune system from attacking melanoma tumors. The FDA's approval comes well before its scheduled review date of March 30.

  • Midday Glance: Pharmaceuticals companies Monday, 22 Dec 2014 | 1:22 PM ET

    Baxter International Inc. rose$. 50 or. 7 percent, to $74.98. Bristol-Myers Squibb Co. fell$. 53 or. 9 percent, to $60.78. Hospira fell$. 25 or. 4 percent, to $62.41.

  • Early Glance: Pharmaceuticals companies Monday, 22 Dec 2014 | 10:22 AM ET

    Baxter International Inc. rose$. 50 or. 7 percent, to $74.98. Bristol-Myers Squibb Co. fell$. 19 or. 3 percent, to $61.11. Johnson& Johnson rose$. 50 or. 5 percent, to $106.05.

  • Final Glance: Pharmaceuticals companies Friday, 19 Dec 2014 | 6:41 PM ET

    Baxter International Inc. rose$. 41 or. 6 percent, to $74.48. Bristol-Myers Squibb Co. rose$. 51 or. 8 percent, to $61.30. Hospira rose$. 22 or. 4 percent, to $62.66.

  • Midday Glance: Pharmaceuticals companies Friday, 19 Dec 2014 | 1:25 PM ET

    Baxter International Inc. rose$. 22 or. 3 percent, to $74.29. Bristol-Myers Squibb Co. rose$. 15 or. 2 percent, to $60.94. Hospira rose$. 18 or. 3 percent, to $62.62.

  • Early Glance: Pharmaceuticals companies Friday, 19 Dec 2014 | 10:20 AM ET

    Baxter International Inc. fell$. 50 or. 7 percent, to $73.57. Bristol-Myers Squibb Co. rose$. 27 or. 4 percent, to $61.06. Hospira fell$. 02 or percent, to $62.42.

  • Final Glance: Pharmaceuticals companies Thursday, 18 Dec 2014 | 8:09 PM ET

    Baxter International Inc. rose $1.80 or 2.5 percent, to $74.07. Bristol-Myers Squibb Co. rose $1.60 or 2.7 percent, to $60.79. Hospira rose $2.19 or 3.6 percent, to $62.44.

  • Midday Glance: Pharmaceuticals companies Thursday, 18 Dec 2014 | 1:48 PM ET

    Baxter International Inc. rose $1.12 or 1.5 percent, to $73.39. Bristol-Myers Squibb Co. rose $1.16 or 2.0 percent, to $60.35. Hospira rose $1.44 or 2.4 percent, to $61.69.

  • Early Glance: Pharmaceuticals companies Thursday, 18 Dec 2014 | 11:11 AM ET

    Baxter International Inc. rose$. 94 or 1.3 percent, to $73.21. Bristol-Myers Squibb Co. rose$. 69 or 1.2 percent, to $59.88. Hospira rose$. 68 or 1.1 percent, to $60.93.

  • Final Glance: Pharmaceuticals companies Wednesday, 17 Dec 2014 | 7:08 PM ET

    Baxter International Inc. rose $1.54 or 2.2 percent, to $72.27. Bristol-Myers Squibb Co. rose $1.50 or 2.6 percent, to $59.19. Hospira rose $1.43 or 2.4 percent, to $60.25.